calcifediol has been researched along with Leukemia, Myeloid in 2 studies
*Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, E; Miyaura, C; Naito, H; Ohmori, M; Shiina, Y; Suzuki, T; Takayama, H; Tanaka, H; Yamada, S; Yamamoto, K | 1 |
| Abe, E; Ino, E; Matsunaga, I; Miyaura, C; Nishii, Y; Shiina, Y; Takayama, H; Tanaka, H; Yamada, S; Yamamoto, K | 1 |
2 other study(ies) available for calcifediol and Leukemia, Myeloid
| Article | Year |
|---|---|
Syntheses and differentiating action of vitamin D endoperoxides. Singlet oxygen adducts of vitamin D derivatives in human myeloid leukemia cells (HL-60).
Topics: Binding, Competitive; Calcifediol; Cell Differentiation; Cell Line; Chemical Phenomena; Chemistry; Cholecalciferol; Cytosol; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid; Oxidation-Reduction; Oxygen; Phagocytosis; Receptors, Calcitriol; Receptors, Steroid; Singlet Oxygen; Structure-Activity Relationship | 1985 |
Mechanism of the differentiating action of 25-hydroxyvitamin D3 endoperoxides in human myeloid leukemia cells (HL-60).
Topics: Animals; Bone Resorption; Calcifediol; Cell Differentiation; Cell Line; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Cytosol; Humans; Leukemia, Myeloid; Mass Spectrometry; Mice; Peroxides; Phagocytosis; Receptors, Calcitriol; Receptors, Steroid; Spectrophotometry, Ultraviolet | 1985 |